77 results
Page 4 of 4
8-K
EX-99.1
rf9e5qbe l43hf
12 Nov 21
Talaris Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
7:00am
8-K
mx5mc6t6j1mz hy
4 Nov 21
Other Events
4:02pm
8-K
EX-99.1
xmx0qk07j33kaurj47
2 Nov 21
Talaris Therapeutics Announces Initiation of Phase 2 Clinical Trial of FCR001 in Delayed Tolerance Induction
4:02pm
8-K
EX-99.1
rx8lvkox748oq1jbyy
12 Aug 21
Talaris Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update
10:35am
10-Q
d9u3xvngli315
14 Jun 21
Quarterly report
4:21pm
8-K
EX-99.1
s5hxlcuzrvm8tcamoc69
14 Jun 21
Talaris Therapeutics Announces First Quarter 2021 Financial Results and Provides Business
4:07pm
8-K
EX-3.2
wklgzxn
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
424B4
89ci921a6g0i9
10 May 21
Prospectus supplement with pricing info
4:20pm
UPLOAD
ftcx8d p25oj4
5 May 21
Letter from SEC
12:00am
S-1/A
EX-3.4
0x8zcd
3 May 21
IPO registration (amended)
6:07am
S-1/A
lph3k87a4
3 May 21
IPO registration (amended)
6:07am
S-1
EX-10.14
xsea57k0q9
16 Apr 21
IPO registration
5:03pm
S-1
m1dgebhph1pf 1pqg
16 Apr 21
IPO registration
5:03pm
S-1
EX-10.15
jkztq 8ks2
16 Apr 21
IPO registration
5:03pm
DRS/A
sy1d4l2nygs jv1
1 Apr 21
Draft registration statement (amended)
12:00am